LONG-TERM SAFETY OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS CLINICAL TRIALS

被引：0
|
作者：
Taylor, A. [1 ]
Nash, P. [2 ]
Hall, S. [3 ]
Jones, G. [4 ]
Youssef, P. [4 ]
Porter-Brown, B. [5 ]
Thompson, L. [5 ]
Genovese, M. [6 ]
机构：
[1] Royal Perth Hosp, Perth, WA, Australia
[2] Univ Queensland, Cotton Tree, Australia
[3] Cabrini Med Ctr, Malvern, Australia
[4] Menzies Res Inst, Hobart, Tas, Australia
[5] Roche, Welwyn Garden City, England
[6] Stanford Univ, Med Ctr, Palo Alto, CA 94304 USA
来源：
INTERNAL MEDICINE JOURNAL | 2012年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：14 / 14
页数：1
相关论文
共 50 条
  • [41] LONG-TERM SAFETY OF TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS FOLLOWING A MEAN TREATMENT DURATION OF 3.9 YEARS (ENCORE)
    Genovese, M.
    Sebba, A.
    Youssef, P.
    Rischmueller, M.
    Jones, G.
    Rubbert-Roth, A.
    Scali, J.
    Alten, R.
    Kremer, J.
    Pitts, L.
    Rowell, L.
    Van Vollenhoven, R.
    [J]. INTERNAL MEDICINE JOURNAL, 2014, 44 : 25 - 25
  • [42] Safety and Efficacy Of Subcutaneous Tocilizumab Monotherapy In a Long-Term Extension Study In Japanese Rheumatoid Arthritis Patients.
    Ogata, Atsushi
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S605 - S606
  • [43] LONG-TERM SAFETY OF TOCILIZUMAB (TCZ) IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) AND A MEAN TREATMENT DURATION OF 3.7 YEARS
    Smith, M.
    Taylor, A.
    Youssef, P.
    Hall, S.
    Nash, P.
    Sebba, A.
    Rubbert-Roth, A.
    Scali, J.
    Alten, R.
    Kremer, J.
    Pitts, L.
    Van Vollenhoven, R.
    Genovese, M.
    [J]. INTERNAL MEDICINE JOURNAL, 2013, 43 : 33 - 33
  • [44] TOCILIZUMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS: LONG-TERM EFFICACY FOR UP TO 3.5 YEARS
    Smolen, J. S.
    Gomez-Reino, J. J.
    Davies, C.
    Alecock, E.
    Rubbert-Roth, A.
    Emery, P.
    [J]. RHEUMATOLOGY, 2010, 49 : I110 - I111
  • [45] GASTROINTESTINAL SAFETY OF TOCILIZUMAB: DATA FROM PATIENTS WITH RHEUMATOID ARTHRITIS IN ROCHE CLINICAL TRIALS AND CLINICAL PRACTICE
    Van Vollenhoven, Ronald
    Keystone, Edward
    Furie, Richard
    Blesch, Anne
    Wang, Candace D.
    Curtis, Jeffrey R.
    [J]. RHEUMATOLOGY, 2010, 49 : I103 - I103
  • [46] Long-Term Safety and Efficacy of Subcutaneously Administered Tocilizumab for Adult Rheumatoid Arthritis: A Multicenter Phase 3b Long-term Extension Study
    Kivitz A.
    Wallace T.
    Olech E.
    Borofsky M.
    Devenport J.
    Pei J.
    Michalska M.
    [J]. Rheumatology and Therapy, 2016, 3 (2) : 291 - 304
  • [47] Safety of tocilizumab in patients with rheumatoid arthritis: Pooled analysis of five phase 3 clinical trials
    Smolen, Josef S.
    Beaulieu, Andre D.
    Dikranian, Ara
    Fenton, Ira
    Fisheleva, Elena
    Alecock, Emma
    Emery, Paul
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S784 - S784
  • [48] Safety and efficacy profiles of tocilizumab monotherapy in Japanese patients with rheumatoid arthritis: meta-analysis of six initial trials and five long-term extensions
    Nishimoto, Norihiro
    Ito, Kyoko
    Takagi, Nobuhiro
    [J]. MODERN RHEUMATOLOGY, 2010, 20 (03) : 222 - 232
  • [49] Short-term and Long-term Safety of Glucocorticoids in Rheumatoid Arthritis
    Saag, Kenneth G.
    [J]. BULLETIN OF THE HOSPITAL FOR JOINT DISEASES, 2012, 70 : S21 - S25
  • [50] Predictors of long-term clinical remission in rheumatoid arthritis
    Fornaro, Marco
    Cacciapaglia, Fabio
    Lopalco, Giuseppe
    Venerito, Vincenzo
    Iannone, Florenzo
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2021, 51 (02)
12345